MB
Mentat Biotechnology, Corp.
SEC filingBiotechnology · Daly City, CA
Amount raised$10Ksold at filing
Total offering$10K
Investors in the raise1count reported to the SEC
FiledMay 4, 2026first sale Apr 16, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Grant GetzelmanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.